Drug intelligence / Profile preview

Joyfinac-MR

Development stage
Unknown
Lead developer
JoY Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Joyfinac-MR is a branded generic fixed-dose combination (FDC) medication marketed by JoY Pharma, a pharmaceutical company based in Bengaluru, India. It is part of the company's anti-inflammatory product range and is primarily indicated for the management of pain and inflammation associated with musculoskeletal disorders, particularly those complicated by muscle spasms. The formulation typically consists of three active ingredients: diclofenac potassium (a non-steroidal anti-inflammatory drug or NSAID), paracetamol (an analgesic and antipyretic), and chlorzoxazone (a centrally acting skeletal muscle relaxant). Diclofenac and paracetamol work synergistically to provide relief from pain and inflammation by inhibiting cyclooxygenase (COX) enzymes and reducing prostaglandin synthesis. Chlorzoxazone acts on the central nervous system, specifically at the level of the spinal cord and subcortical areas of the brain, to inhibit multi-synaptic reflex arcs involved in producing and maintaining muscle spasms. This combination therapy is designed to address both the inflammatory pain and the physical stiffness associated with conditions such as strains, sprains, and back pain.

Brand names
Joyfinac-MR
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Joyfinac-MR.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Joyfinac-MR.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call